CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | July/August 2020

Transcatheter Solutions for Mitral/Tricuspid Valves

By Fabien Praz, MD, and Rishi Puri, MD

cit | Article | March/April 2021

2020 ACC/AHA Guideline for Management of Patients With Valvular Heart Disease

Experts share their views on how these new guidelines will impact practice.

With Gorav Ailawadi, MD; Mario J. Garcia, MD, FACC; Rishi Puri, MD, PhD; and Vinod H. Thourani, MD

cit | Article | September/October 2023

Curbside Consult: The Biggest Clinical Trial Innovation Needs in…

Physicians consider priorities for future clinical trials in their respective interventional cardiology areas of focus, with responses spanning from a need for data informing treatment benefit and decision-making for current and future therapies to broader changes needed in the approach to research.

With Mirvat Alasnag, MD, FACC, FACP, FSCAI, FRCP; Salvatore Brugaletta, MD, PhD; Jay Giri, MD, MPH, FACC, FAHA, FSCAI; Rasha Al-Lamee, MA, MBBS, FRCP, PhD; Rishi Puri, MD, PhD, FRACP; and Gagan D. Singh, MD

cit | News | July 16, 2017

ANCHOR OCT Surveillance Study Evaluates iVascular's Angiolite Sirolimus-Eluting Stent System

July 17, 2017—The ANCHOR study evaluating 3- and 6-month optical coherence tomographic (OCT) surveillance following percutaneous coronary intervention with the cobalt chromium Angiolite sirolimus-eluting stent system (iVascular) was published by Rishi Puri, MD, et al online ahead of print in Catheterization and Cardiovascular Interventions.

Advertisement

Advertisement

cit | News | March 31, 2025

One-Year Patient Outcomes Presented for Anteris DurAVR THV

March 31, 2025—Anteris Technologies Global Corp.

cit | News | March 12, 2024

Abbott Presents Studies of Portico, Navitor, and Amplatzer Amulet Devices

March 12, 2024—At CRT 2024, the Cardiovascular Research Technologies annual meeting held March 9-12 in Washington, DC, Abbott presented findings from studies of three of the company’s devices for cardiac interventions: the Portico transcatheter aortic valve replacement (TAVR) system, the Navitor TAVR device, and the Amplatzer Amulet left atrial appendage occluder (LAAO).

cit | News | December 22, 2020

P+F’s TricValve System Granted FDA Breakthrough Device Designation

December 22, 2020—P+F Products + Features GmbH announced that FDA has granted Breakthrough Device designation for the company’s TricValve transcatheter bicaval valves system.

cit | News | September 19, 2022

Advanced NanoTherapies’ SirPlux Duo DCB Receives FDA Breakthrough Device Designation for Small-Vessel CAD

September 19, 2022—Advanced NanoTherapies, Inc. announced that the FDA has granted Breakthrough Device designation for the company’s SirPlux Duo drug-coated balloon (DCB) for the treatment of coronary artery disease in vessels < 3 mm.

cit | News | August 22, 2023

Advanced NanoTherapies Enrolls First Patients, Receives Additional Funding for Study of SirPlux Duo DCBs

August 22, 2023—Advanced NanoTherapies Inc. (ANT) announced two milestones in the development of its SirPlux Duo drug-coated balloon (DCB) for the treatment of de novo coronary artery disease (CAD): (1) the first 10 patients were enrolled in ADVANCE-DCB, and (2) additional Series A funding for the development of their DCB was secured.

cit | Article | September/October 2023

Modern Clinical Trials Spotlight

By Ori Ben-Yehuda, MD

cit | Article | March/April 2021

Contemporary Issues in TAVR

By James McCabe, MD, and Darren Mylotte, MD


1

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button